Company Performance Metrics
- Derek Lee: CSO
- JinSeok Kang: CEO and RnD Director
iGentech's platform is focused on developing high-precision, compact, all-in-one automated equipment and diagnostic reagents that can be immediately deployed on-site in response to the changing trends in testing from automated equipment-based hospitals and medical examination centers to on-site testing needs by accumulating and integrating key
technologies and in various fields such as biotechnology, materials, machinery, and computers, to develop practical platforms and leveraging the expertise of its core personnel to rapidly commercialize and enhance the on-site applicability of molecular and immune diagnostics, thereby providing customers with optimal solutions for rapid disease diagnosis and treatment through products that offer user-friendliness and high confidence in the results.